2013
DOI: 10.1136/bjophthalmol-2013-303235
|View full text |Cite
|
Sign up to set email alerts
|

New insights into the visual prognosis of pseudoxanthoma elasticum

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2015
2015
2025
2025

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 4 publications
0
3
0
Order By: Relevance
“…Visual impairment is common in patients with PXE, and the visual acuity of the first eye often deteriorates around the fifth decade. 7,[26][27][28] Because most but not all patients with PXE develop CNV or macular atrophy, the visual prognosis varies and is difficult to predict for an individual. 7 For patients with PXE, the foresight of losing vision impacts their quality of life, emotional well-being, and decisions in life planning.…”
Section: In This Study We Developed a Measure For The Extentmentioning
confidence: 99%
“…Visual impairment is common in patients with PXE, and the visual acuity of the first eye often deteriorates around the fifth decade. 7,[26][27][28] Because most but not all patients with PXE develop CNV or macular atrophy, the visual prognosis varies and is difficult to predict for an individual. 7 For patients with PXE, the foresight of losing vision impacts their quality of life, emotional well-being, and decisions in life planning.…”
Section: In This Study We Developed a Measure For The Extentmentioning
confidence: 99%
“…PXE also affects retina, inducing fragmentation and rupture of calcified elastin fibers of the Bruch's membrane. The examination of the fundus of the eye reveals a typical "peau d'orange" aspect in PXE patients, with angioid streaks and choroidal neovascularization leading to hemorrhages [8,9]. When affecting the macula, these lesions lead to the loss of central vision.…”
Section: Clinical Manifestationsmentioning
confidence: 99%
“…To date, there is no specific curative or preventive therapy for PXE patients. Bisphosphonates such as Etidronate seem promising to prevent cardiovascular calcifications and anti-Vascular Endothelial Growth Factor (VEGF) intraocular injections limit neoangiogenesis [9,16,17].…”
Section: Clinical Manifestationsmentioning
confidence: 99%